ADVERTISEMENT
search.svg

Featured Education

Upcoming Events

Practice Resources

Tools and resources to support your practice


image-6
image-7 image-8
 

Latest from APhA

View CEO Blog

Workplace conditions and well-being

We hear you! Your pharmacy workplace is stressed and stretched. You have rapidly growing concerns for patient safety. Still, you are there—every day—to care for your patients despite conditions that seem to be working against you.

RSS

American Pharmacists Association Announces 2022 APhA Fellows

The American Pharmacists Association (APhA) today announced the selection of the APhA Fellows as part of the 2022 APhA Awards and Honors Program.

RSS

Pharmacy news

View all news

Update on biosimilars: Recent approvals, role for pharmacists

This year has seen the approval of 2 new biosimilar drugs, including the first biosimilar to earn FDA’s “interchangeable” designation. Byooviz (ranibizumab-nuna) is biosimilar to Lucentis (ranibizumab), a drug for neovascular (wet) age-related macular degeneration (nAMD). Semglee (insulin glargine-yfgn), the first such drug to earn the “interchangeable” distinction, is biosimilar to Lantus (insulin glargine) for diabetes.

Autism prevalence higher in CDC’s monitoring network

New data from CDC’s Autism and Developmental Disabilities Monitoring (ADDM) network show that 2.3% of children aged 8 years in 11 communities across the United States had an autism diagnosis in 2018.

RSS